dorfmanmaster

dorfmanmaster

Earnings/News Co's lead cancer therapy, trilaciclib, gets FDA's "breakthrough therapy" status, which is meant to speed up review of drugs that treat life-threatening conditions GTHX says it will present new data on three of its drugs, including trilaciclib, at an upcoming conference in September FDA's move is a recognition that clinical data presented...

dorfmanmaster

News/fundamental The USTR says that the tariffs on some items, including “certain toys,” will be delayed until Dec. 15. September is a key shipping month for those companies as they prepare for the holiday shopping season, when the majority of the industry’s business occurs. Hasbro told CNBC earlier this month that it would have “no choice but to pass...

dorfmanmaster

Fundamental data IBM reported earnings and reaffirmed guidance. It was up over 5% on the news. Trade-war: "The U.S. Trade Representative said Tuesday 10% tariffs on about $300 billion in Chinese imports will go forward, but tariffs on some goods will be delayed until Dec. 15. Those items include cellphones, laptop computers , video game consoles, some toys,...

dorfmanmaster Updated 

This coming Tuesday 13th, Douyu will report earnings for the first time. DOYU is 28% below its IPO price. Buyers probably won't let DOYU continue to slide.

dorfmanmaster

Roku (ROKU) August weekly 101 straddle priced for a move of 16.5% into the expected release of quarterly results after the bell on August 7th 2019. What is a straddle: A straddle entails buying a call and put of the same strike that allows the holder to profit based on how much the price of the underlying security moves, regardless of the direction of price...

dorfmanmaster

Fundamental analysis Earnings was pretty bad for Netapp as they slashed guidance. Market sentiment is complicated right now, if a stock doesn't do well fundamentally, it really takes a toll. Technical analysis Support around $36-38

dorfmanmaster Updated 

The fed is set to talk today. As you might know, the fed states his decision based on If J. Powell uses the words "Risk balance". The stock market is in BIG TROUBLE. What this would mean is he would cut rates only once . And the market has already baked in at least 3 more. IF J. Powell used the words "Going forward". The stock market might be in...

dorfmanmaster

A way to take advantage of volatility on this market could be this short-term futures based on the $VIX. For more ideas and analysis with premium sources... Please suscribe!

dorfmanmaster

Fundamental Analysis It appears Capital One isn’t the only company affected by this--it’s just the first company to publicly acknowledge it has been hacked and the most proactive in addressing the security situation. Meaning... as soon as other companies report the same, they will get the bad attention. Because of the breach they will lose $150M-300M,...

dorfmanmaster

Fundamental analysis MOG.A dropped 15% in 2 days, after beating earnings, revenue, and reaffirms FY19 EPS guidance. Analyst lowered price target from $102 to $92 Technical analysis OBV did not fall below it's high since late June. RSI(10) @30.5, not wanting to go into oversold territory. *Note: If the stock market rallies tomorrow with the fed...

dorfmanmaster

SANM last 12 quarters have seen positive only reactions. - Past performance is no guarantee of future results, but history does rhyme. Technicals RSI(10) @70 reaching higher OBV growing as the price does the same. Acting great with above average volume before earnings. I see a potential move of 10%-15%.

dorfmanmaster

I am not playing BYND, there are far too many people who lost money shorting this. They might be coming back for some more beating... On the other hand, do you actually believe BYND shares are worth more than $200 ? The option straddle is pricing a 20% move on earnings reported today (Monday 29th) after close. I think it might change even more. Specially on a...

dorfmanmaster

FLEX is suffering from the trade-war between Trump and Xi (US and China). Huawei is "angered" at how FLEX has managed the situation. They report earnings today after hours. (July 25th) I would sell all my position right away.

dorfmanmaster

Technical analysis (daily chart) RSI(10) @62 OBV on steady uptrend along with the RSI CCI(10) @100 MACD > MACDsignal Fundamental analysis BABA is a buy right now @$177. Well below analyst price average targets of $225. (Over 25%) Fair value Morningstar note Our fair value estimate is $240 per ADS incorporates management's full-year fiscal 2020...

dorfmanmaster

Averaging the move of past earnings and options data. Facebook will move about 7% up or down . *Note this is not a short or long - but a volatility study... This way you can measure how much you will win/lose on positive or negative surprises.

dorfmanmaster

RAD has been profiting of Amazon using it's stores. Which is basically saving the company. RAD is finding support again around $6.4, not getting to oversold levels! (RSI(10) < 30) Be mindful that today's volume is below the average volume (which is a bearish sign on a pullback). Important to check today's price & volume at close.

dorfmanmaster

Fundamentals Analysts are pricing BUD @$118 (24% above current price!) New products and hype. Technicals OBV has been increasing steadily. But on a longer term, you can see the average volume is now lower than previous years. BUD is breaking above a weekly resistance 50SMA.

dorfmanmaster

Morningstar weekly highlights set Biomarin Pharmaceuticals with an amazing $119 fair price value ( 50% above current price). Rating: 4 stars Uncertainty rating: Medium Moat: Narrow